{"id":84084,"date":"2023-11-13T16:47:46","date_gmt":"2023-11-13T21:47:46","guid":{"rendered":"https:\/\/ifintechworld.com\/investing\/aurinia-pharmaceuticals-partner-files-nda-in-japan-for-voclosporin\/"},"modified":"2023-11-13T16:47:47","modified_gmt":"2023-11-13T21:47:47","slug":"aurinia-pharmaceuticals-partner-files-nda-in-japan-for-voclosporin","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=84084","title":{"rendered":"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin"},"content":{"rendered":"<div id=\"js-article__body\" itemprop=\"articleBody\" data-sbid=\"MW-BT-CO-20231113-703343\" role=\"document\">\n<p>By Chris Wack<\/p>\n<pre><\/pre>\n<p>Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the treatment of lupus nephritis with the Japanese Ministry of Health, Labor and Welfare.<\/p>\n<div class=\"paywall\">\n<p>The NDA is for the manufacture and sale in Japan of voclosporin, a second-generation oral calcineurin inhibitor for the treatment of lupus nephritis, a complication of the autoimmune disease systemic lupus erythematosus that impacts the kidneys.<\/p>\n<p>Aurinia is eligible to receive a payment of $10 million upon approval in Japan along with low double-digit royalties on net sales once launched.<\/p>\n<p>In January 2021, the U.S. Food and Drug Administration approved voclosporin in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active LN and it is currently available in the U.S. under the brand name Lupkynis.<\/p>\n<p>Aurinia and Otsuka entered a collaboration and licensing agreement in December 2020 for the development and commercialization of voclosporin for the treatment of LN in the EU, Japan, the U.K., Russia, Switzerland, Norway, Belarus, Iceland, Liechtenstein and Ukraine.<\/p>\n<pre><\/pre>\n<p>Write to Chris Wack at chris.wack@wsj.com<\/p>\n<pre><\/pre>\n<\/p><\/div>\n<\/div>\n<p>Read the full article <a href=\"https:\/\/www.marketwatch.com\/story\/aurinia-pharmaceuticals-partner-files-nda-in-japan-for-voclosporin-ad7050df?mod=investing\" target=\"_blank\" rel=\"noopener\">here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the treatment of lupus nephritis with the Japanese Ministry of Health, Labor and Welfare. The NDA is for the manufacture and sale in Japan of voclosporin, a second-generation oral calcineurin inhibitor for the treatment of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1898,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"video","meta":{"footnotes":""},"categories":[239],"tags":[83],"class_list":["post-84084","post","type-post","status-publish","format-video","has-post-thumbnail","hentry","category-investing","tag-featured","post_format-post-format-video"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin | iFintechWorld<\/title>\n<meta name=\"description\" content=\"By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=84084\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=84084\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-13T21:47:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-13T21:47:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=84084#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=84084\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin\",\"datePublished\":\"2023-11-13T21:47:46+00:00\",\"dateModified\":\"2023-11-13T21:47:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=84084\"},\"wordCount\":196,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=84084#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=84084\",\"url\":\"https:\/\/ifintechworld.com\/?p=84084\",\"name\":\"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-11-13T21:47:46+00:00\",\"dateModified\":\"2023-11-13T21:47:47+00:00\",\"description\":\"By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=84084#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=84084\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=84084#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin | iFintechWorld","description":"By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=84084","og_locale":"en_US","og_type":"article","og_title":"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin | iFintechWorld","og_description":"By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the","og_url":"https:\/\/ifintechworld.com\/?p=84084","og_site_name":"iFintechWorld","article_published_time":"2023-11-13T21:47:46+00:00","article_modified_time":"2023-11-13T21:47:47+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/mw_logo_social.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=84084#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=84084"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin","datePublished":"2023-11-13T21:47:46+00:00","dateModified":"2023-11-13T21:47:47+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=84084"},"wordCount":196,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=84084#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=84084","url":"https:\/\/ifintechworld.com\/?p=84084","name":"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-11-13T21:47:46+00:00","dateModified":"2023-11-13T21:47:47+00:00","description":"By Chris Wack Aurinia Pharmaceuticals said Monday that collaboration partner Otsuka Pharmaceutical filed a new drug application for voclosporin for the","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=84084#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=84084"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=84084#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Aurinia Pharmaceuticals Partner Files NDA in Japan for Voclosporin"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/84084","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=84084"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/84084\/revisions"}],"predecessor-version":[{"id":84085,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/84084\/revisions\/84085"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/1898"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=84084"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=84084"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=84084"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}